Nevertheless, decreased expression and mutations of filaggrin-2 (FLG2), also from EDC, have been associated with persistent symptoms of AD in AA, while such variations are absent or infrequently found in AD patients of European ancestry (29). Here, FLG2 is linked to Alzheimer disease.